If you have been invested in Xoma (XOMA) over the past year you have been in for a pretty wild roller coaster ride. The company was approaching $4 per share only to tumble down to about $1.00 per share and then move right back up to $4 per share. Likely some just held on while the peaks and valleys past, but some active traders have made a pretty penny. The big question is whether or not this stock will cycle with more peaks and valleys or begin to move up and test new waters.
I look at Xoma as an incubator of sorts. The company develops and researches medical solutions and typically partners with or...
Only subscribers can access this article, which is part of the PRO research library covering 3,573 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: